M&A Research Institute Holdings Inc.
TSE:9552.T
2279 (JPY) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3,778.417 | 4,244.697 | 3,626.098 | 4,900.395 | 2,305.751 | 2,462.206 | 1,749.519 | 2,125.041 | 1,094.12 | 1,065.1 |
| Cost of Revenue
| 1,371.325 | 1,191.02 | 1,114.817 | 862.994 | 753.229 | 530.671 | 427.46 | 339.737 | 320.616 | 189.344 |
| Gross Profit
| 2,407.092 | 3,053.677 | 2,511.281 | 4,037.401 | 1,552.522 | 1,931.535 | 1,322.059 | 1,785.304 | 773.504 | 875.756 |
| Gross Profit Ratio
| 0.637 | 0.719 | 0.693 | 0.824 | 0.673 | 0.784 | 0.756 | 0.84 | 0.707 | 0.822 |
| Reseach & Development Expenses
| 0 | 0 | 4.633 | 4.403 | 4.283 | 4.036 | 3.988 | 3.431 | 1.924 | 2.065 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 93 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 522 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 1,018.227 | 972.062 | 921.698 | 679.754 | 579.358 | 604.486 | 429.064 | 383.517 | 348.776 | 259.932 |
| Other Expenses
| 0 | 0 | -0.133 | -0.029 | -22.519 | -69.437 | -1.731 | -0.634 | 2.759 | -7.985 |
| Operating Expenses
| 1,018.227 | 972.062 | 926.331 | 684.157 | 583.641 | 608.522 | 433.052 | 386.948 | 350.7 | 261.997 |
| Operating Income
| 1,388.865 | 2,081.615 | 1,584.95 | 3,353.244 | 968.881 | 1,323.013 | 889.007 | 1,398.356 | 422.804 | 613.759 |
| Operating Income Ratio
| 0.368 | 0.49 | 0.437 | 0.684 | 0.42 | 0.537 | 0.508 | 0.658 | 0.386 | 0.576 |
| Total Other Income Expenses Net
| -5.179 | 1.204 | -0.395 | -0.284 | -22.72 | -69.537 | -1.794 | -0.706 | -2.308 | -11.654 |
| Income Before Tax
| 1,383.686 | 2,082.819 | 1,584.555 | 3,352.96 | 946.161 | 1,253.476 | 887.213 | 1,397.65 | 420.496 | 602.105 |
| Income Before Tax Ratio
| 0.366 | 0.491 | 0.437 | 0.684 | 0.41 | 0.509 | 0.507 | 0.658 | 0.384 | 0.565 |
| Income Tax Expense
| 93.701 | 757.46 | 586.668 | 1,177.546 | 726.705 | 393.125 | 278.995 | 438.81 | 234.805 | 188.926 |
| Net Income
| 1,289.984 | 1,325.359 | 997.888 | 2,175.413 | 219.455 | 860.352 | 608.217 | 958.84 | 185.692 | 413.179 |
| Net Income Ratio
| 0.341 | 0.312 | 0.275 | 0.444 | 0.095 | 0.349 | 0.348 | 0.451 | 0.17 | 0.388 |
| EPS
| 21.95 | 22.62 | 17.04 | 37.25 | 3.79 | 14.93 | 10.57 | 16.66 | 2.79 | 6.03 |
| EPS Diluted
| 21.95 | 20.64 | 15.5 | 33.99 | 3.39 | 13.43 | 9.49 | 14.98 | 2.79 | 6.03 |
| EBITDA
| 1,406.54 | 2,088.108 | 1,597.567 | 3,361.414 | 978.654 | 1,329.923 | 894.762 | 1,401.892 | 426.59 | 617.006 |
| EBITDA Ratio
| 0.372 | 0.492 | 0.441 | 0.686 | 0.424 | 0.54 | 0.511 | 0.66 | 0.39 | 0.579 |